Research

At B. Riley, our research process is an interactive one where we perform extensive due diligence on companies until the analyst develops the knowledge base and understanding of the company and the industry to make a recommendation. Our analysts continuously monitor industry developments and communicate with the management, competitors, suppliers and customers of the companies we follow, regularly communicating our findings through Research Updates and daily Morning Notes.

While we do not necessarily publish research on all of the companies we review, the knowledge base and understanding of many of our monitored companies parallels that of our covered companies. We actively cover over 100 companies and monitor an additional 100. Our analysts cover small to mid-cap companies that are under-followed or misunderstood by Wall Street. We believe that the pricing of small cap equities is frequently inefficient, and therefore provides the greatest potential rewards to diligent security analysis.

This Week's Research

  • 11/26/14 Morning Note B. Riley & Co. Morning Notes: ADI, DSW, IEC, MAMS, TIVO, XCRA
  • 11/26/14 Update TIVO ($12.91, Buy; $20.00 PT): Upside Q3 Results on Record MSO Subscriber Gains; Domestic Tier 2 MSOs Remain EBITDA Driving Force with New Deals as…
  • 11/26/14 Update IEC ($5.30, Buy; $7.25 PT): Turnaround in Progress: Revenue up 8% Sequentially; Backlog up 21% y-o-y; Margins Light but Expects Continued Growth and…
  • 11/26/14 Update XCRA ($8.06, Buy; $11.00 PT): Results Beat But Big Drop In The Outlook Resets Earnings Expectations
  • 11/26/14 Update ADI ($52.70, Buy; $62.00 PT): Better Than Feared Print And Outlook Augurs Well For C15; Tgt Is $62.0
  • 11/26/14 Update DSW ($34.38, Buy; $39.00 PT): Top/Bottom Line Beat; +2.6% Comp; Earnings Recovery in Sight/ Focus Turns to Growth; Raising Estimates and PT from $37…
  • 11/25/14 Initiation of Coverage MAMS ($5.34, Buy; $8.00 PT): Initiating Coverage With a Buy Rating and $8.00 PT
  • 11/25/14 Update TUP ($67.33, Neutral; $72.00 PT): Dollar Is Up More, Street Expectations for 2015 Local Currency EPS Growth Seem High, Yet Stock +7%—Downgrading…
  • 11/25/14 Update BV ($7.43, Buy; $10.00 PT): Q2 ’15 Earnings Preview; Reiterate Buy Rating and $10.00 Price Target
  • 11/25/14 Update OUTR ($71.39, Neutral; $62.00 PT): Redbox Price Hikes to Positively Boost Near-Term Profitability; Longer-Term Model Impact Around Consumer Reactions…
  • 11/25/14 Morning Note B. Riley & Co. Morning Notes: AMSWA, ATNY, BV, CVU, OUTR, TUP, WTSL; Consumer Products Weekly (EL, IPAR, NWL, PG, PRGO)
  • 11/25/14 Update AMSWA ($9.30, Buy; $12.50 PT): Q2 ’15 Earnings Preview; Reiterate Buy Rating and $12.50 Price Target
  • 11/24/14 Update Household/Personal Care: Weekly Highlights (BRK.A, EL, IPAR, NWL, PG, PRGO)
  • 11/24/14 Update IEC ($5.34, Buy; $7.25 PT): Earnings Preview: IEC Righting Ship in Q4 (Sep); Facing Proxy Battle Just as Resolving SCB Derivative Claims
  • 11/24/14 Morning Note B. Riley & Co. Morning Notes: ADI, IEC, LGF; Exhibitors (AMC, CKEC, CNK, MCS, RGC)
  • 11/24/14 Update LGF ($33.25, Buy; $40.00 PT): HG3 Fails to Satisfy Domestic Appetites…But Overseas Movie-Goers Come Back for Seconds; Comfortable with $850MM GBO…
  • 11/24/14 Update ADI ($51.65, Buy; $62.00 PT): Expect ADI In-Line To Slightly Lower Ahead Of 1H15 Acceleration
  • 11/21/14 Update MRVL ($13.25, Buy; $18.50 PT): Better OpEx Cushions Lower Sls; Stock Cheap, Add For Upside To $18.50
  • 11/21/14 Morning Note B. Riley & Co. Morning Notes: BBY, GME, INTC, LGF, MRVL, RNWK
  • 11/21/14 Update GME ($43.87, Buy; $64.00 PT): Defending GME On 3Q Miss - Not Time To Throw In The Towel
  • 11/21/14 Update INTC ($35.95, Buy; $40.00 PT): Analyst Day C15 Growth And Excess Cash Outlook Is Better; Buy, $40 PT
  • 11/21/14 Update RNWK ($6.73, Buy; $12.50 PT): Current Market Valuation Assigns Zero Contribution from the Valuable 45% Stake in Rhapsody – Which Makes Absolutely…
  • 11/20/14 Update BBY ($38.30, Buy; $47.00 PT): 3Q Surprises And Outlook Remains Strong; Raising PT To $47
  • 11/20/14 Morning Note B. Riley & Co. Morning Notes: EXAR, NSSC, OPLK, RUBI, SMTC, SPLS, SSI, XCRA
  • 11/20/14 Update RUBI ($13.49, Buy; $21.00 PT): Increasing Product Suite Opens New Market Opportunities – RUBI to Participate in AAPL’s New Advertising Battlefront;…
  • 11/20/14 Update OPLK ($24.18, Neutral; $24.25 PT): To Be Acquired by Koch for $24.25 per share; Lowering PT from $26.25 to $24.25; Downgrading from Buy to Neutral
  • 11/20/14 Update EXAR ($8.60, Buy; $13.00 PT): Takeaways From The Road With Management; PT $13.0
  • 11/20/14 Update SSI ($18.79, Neutral; $19.50 PT): Q3 beat partially due to better selling of clearance merch; AUR up, but merch margin, UPT and transaction count…
  • 11/20/14 Update SPLS ($13.92, Neutral; $14.00 PT): 3Q Review: Sentiment Shift Trumps Fundamentals, Upside Limited
  • 11/20/14 Update SMTC ($23.00, Neutral; $26.00 PT): Results and Outlook Below Street Ex-One Time Items, PT To $26.0
  • 11/20/14 Update XCRA ($7.96, Buy; $13.25 PT): Earnings Preview: Expect In Line F1Q15 Results But Lowering F2Q15 Ests
  • 11/19/14 Initiation of Coverage NSSC ($4.56, Neutral; $4.40 PT): Initiating Coverage with a Neutral Rating and a $4.40 Price Target